News
  • News
  • Perspectives
  • Dennis Chang Leads Seminar at MIT’s Koch Institute

    MIT Seminar 5-24-17

    Clarion Healthcare was recently invited by the MIT Biotechnology Group (MBG), a student organization with more than 2000 members, to give a seminar to the MIT and broader life-sciences community at the Koch Institute for Integrative Cancer Research.  In his seminar titled “Navigating Uncharted Waters: Clinical Strategy Amid Rapid Innovation” Principal Dennis Chang, PhD, articulated the key challenges in clinical development for the biopharma industry in the context of unprecedented pace of innovation and described possible strategic approaches to tackle them.

    With more than 60 graduate students, post-docs, entrepreneurs and industry professionals participating, Dennis shared insights from two of Clarion’s noteworthy initiatives on the topic.  First, he presented examples from Clarion’s “Strategic Pathway Research in Cancer “(SPARC), a formal approach to anticipating future innovation and to pipeline prioritization.  Second, he shared the “Collaborative Novel-Novel Combination Therapies” (CoNNCT) approach to accelerating early testing of novel-novel combinations which was designed together with more than 40 industry and nonprofit leaders.

    Following the highly interactive seminar, Bobby Moy, a Principal at Clarion, led an invitation-only educational session on the essentials of conducting due diligence in the life sciences.   In addition to providing tips and techniques, Bobby offered feedback on MBG projects, supporting the group in building in-house expertise to provide technical and strategic analysis to VC’s and MIT angel investors.


    Dr. Amama Sadiq Promoted to New Role as Medical Director at Clarion Healthcare

    Amama photo v1April, 2017 – Clarion Healthcare is pleased to announce that Amama Sadiq, MD, MPH, has been promoted to the newly created role of Medical Director at Clarion Healthcare.  In this role, Dr. Sadiq will provide specific medical and clinical insights and guidance across Clarion projects as well as help the firm identify and respond to health industry evolutionary forces critical to our clients’ success.

    Before joining Clarion in 2014, Dr. Sadiq practiced Internal Medicine in London where she received subspecialty training in GI and hepatology and developed a lifelong passion to advance care and treatment of liver disorders including NAFLD and hepatitis.  Dr. Sadiq has also earned an MPH in Health Policy and Management from Harvard, which — combined with her International Health Care Systems experience — provides her with a uniquely multi-faceted knowledge base for Clarion’s global clients.

    “Amama’s knowledge, skills and experience converge in her role as Medical Director at Clarion, creating value along many dimensions for our clients and for Clarion,” said Tom Murtagh, Managing Director.  “Her years in the clinic treating patients, combined with her innovative research, public health expertise and clinical research experiences will offer insight into the priorities of many important stakeholders for biopharma companies.”

    “I’m thrilled with this new opportunity,” stated Dr. Sadiq.  “I derive tremendous satisfaction working with clients to help them bring novel therapies to patients, and serving as Clarion’s Medical Director allows me to apply more deeply the knowledge I gained from my many years of training and providing care as a physician, a researcher, and a public health professional.”


    Company and Product Valuation through the Lens of Life Science Investors

    Mauricio snipClarion’s six-part Financial Speaker Series continued with a program on life science investment and valuation presented by Clarion Manager and Tuck School of Business MBA Mauricio de la Garza.  This series — a unique element of Clarion’s continuing professional development — provides a range of perspectives on finance in the life sciences industry involving experts from venture capital, investment banking, start-ups and publically traded companies as well as internal experts to broaden and deepen the insights of the Clarion team.

    “Understanding the roles of investors in the broader biotech ecosystem helps Clarion consultants better develop solutions for companies at each stage of the funding journey,” said Mauricio.  “With this session we provided context and opportunity for discussion and learning about different types of funding, objectives of funders, and methods of valuation.”

    In addition to clarifying the roles and impact of different types of funders over time, the session also covered both industry financing trends and tools for valuation.  “Approaches to company and product valuation differ based on context” said Tom Murtagh, Clarion Managing Director.  ”By combining methodology training together with the real world perspectives offered by seasoned investors and VC’s we’re able to significantly expand the knowledge and expertise base of our Clarion Healthcare team.”

    These insights complement previous discussions about equity market analysis and set the stage for future presentations on specific company journeys and venture financing.

    Clarion’s Financial Speaker Series program is part of Clarion’s broader Industry Leaders Development Program, specifically designed to serve the dual purpose of enriching our team’s consulting skill set while exposing firm members to the spectrum of industry roles and opportunities. This program is core to Clarion’s mission of supporting client innovation together with developing future industry leaders within our staff.


    Clarion Makes an Impact on Boston Families in Need This Holiday Season

    30179310-30179310Clarion Healthcare is kicking off the holiday season by participating in the “Big Wishes Gift Drive” in support of the Home for Little Wanderers in Boston. Clarion has been “adopting” families for more than 10 years, providing items ranging from household necessities like pots and pans, to clothing and toys for the children.  “Over the years we’ve supported more than 20 families during the holidays,” said Dominick Mastropoalo, Principal at Clarion. “We are dedicated in our work to making a positive and lasting impact both on our clients and – indirectly — on the patients they serve.  By partnering with the Home for Little Wanderers, the oldest childcare services organization in the country, we can have a small but direct impact on families in need in the surrounding Boston community.” For more information about the organization, click here.


    Clarion Director Elected to Leadership Role with Healthcare Businesswomen’s Association

    jessica-photo

    Jessica Blaustein, Director of Development for Clarion Healthcare, has been elected to the Board of Directors of the Boston chapter of the Healthcare Businesswomen’s Association (HBA) as Director of the Executive Women’s Series.  Previously, Jessica was Director of Volunteer Engagement.   In her new role, Jessica will lead programming for senior executives in support of HBA’s mission to further the advancement and impact of women in the business of healthcare.  HBA is a non-profit organization with more than 1,000 members in the Boston chapter and 8,000 members worldwide.

    “I value the opportunity to contribute to the mission of HBA and have greatly appreciated the support provided to me and to the HBA organization by the Partners at Clarion,” said Jessica.  “Both organizations share a deep commitment to leadership development and have provided me with outstanding opportunities for professional growth.”


    Clarion News

    Home | Contact | Terms & Conditions | Login

    © 2011 - Clarion Healthcare - All Rights Reserved